AMRI Announces Third Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Albany Molecular Research (AMRI) Tops Q3 EPS by 1c
November 5, 2015 7:19 AM ESTAlbany Molecular Research (NASDAQ: AMRI) reported Q3 EPS of $0.14, $0.01 better than the analyst estimate of $0.13. Revenue for the quarter came in at $101.4 million versus the consensus estimate of $95.15 million.
Albany Molecular Research reaffirmed FY2015 guidance.
For earnings history and earnings-related data on Albany Molecular Research (AMRI) click here.
... More


